Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the original STEP 1 trial, adults with overweight or obesity who took semaglutide alongside lifestyle intervention lost an average of nearly 15 percent of their body weight over 68 weeks, compared with about 2 percent in the placebo group
Learn more: Everything to know about Zepbound dosage Weight loss results on Zepbound vary, but clinical trials have reported weight loss of more than 10% of body weight in people taking tirzepatide for 72 weeks (1.5 years)
Low blood sugar can also cause weakness, difficulty concentrating and low energy
you are likely to be less depressed and anxious and will have better memory and mental acuity
Muscle Retention: SLU-PP-332 may counter muscle loss from GLP-1 therapy
Protecting your joints while young ensures long-term mobility
US$ 26.56
US$ 26.35
US$ 20.19
US$ 21.49
US$ 28.09
US$ 25.50
US$ 27.29
